DK2155733T3 - Cykliske lactamer til behandling af glaukom eller forhøjet intraokulært tryk - Google Patents

Cykliske lactamer til behandling af glaukom eller forhøjet intraokulært tryk

Info

Publication number
DK2155733T3
DK2155733T3 DK08755837.5T DK08755837T DK2155733T3 DK 2155733 T3 DK2155733 T3 DK 2155733T3 DK 08755837 T DK08755837 T DK 08755837T DK 2155733 T3 DK2155733 T3 DK 2155733T3
Authority
DK
Denmark
Prior art keywords
glaucoma
treatment
intraocular pressure
elevated intraocular
cyclic lactams
Prior art date
Application number
DK08755837.5T
Other languages
English (en)
Inventor
David W Old
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Application granted granted Critical
Publication of DK2155733T3 publication Critical patent/DK2155733T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
DK08755837.5T 2007-05-23 2008-05-19 Cykliske lactamer til behandling af glaukom eller forhøjet intraokulært tryk DK2155733T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93977307P 2007-05-23 2007-05-23
PCT/US2008/064073 WO2008144623A1 (en) 2007-05-23 2008-05-19 Cyclic lactams for the treatment of glaucoma or elevated intraocular pressure

Publications (1)

Publication Number Publication Date
DK2155733T3 true DK2155733T3 (da) 2012-10-29

Family

ID=39522202

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08755837.5T DK2155733T3 (da) 2007-05-23 2008-05-19 Cykliske lactamer til behandling af glaukom eller forhøjet intraokulært tryk

Country Status (13)

Country Link
US (2) US8198315B2 (da)
EP (1) EP2155733B1 (da)
JP (1) JP5524047B2 (da)
AU (1) AU2008254717B2 (da)
BR (1) BRPI0812385A2 (da)
CA (1) CA2688897A1 (da)
CY (1) CY1113448T1 (da)
DK (1) DK2155733T3 (da)
ES (1) ES2395875T3 (da)
PL (1) PL2155733T3 (da)
PT (1) PT2155733E (da)
SI (1) SI2155733T1 (da)
WO (1) WO2008144623A1 (da)

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0035689B1 (en) 1980-02-28 1984-12-19 Fujisawa Pharmaceutical Co., Ltd. 4-substituted-2-oxoazetidine compounds, processes for their preparation, and their use for preparing antibiotics
GB2101114B (en) 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
US5212176A (en) 1990-06-29 1993-05-18 Abbott Laboratories R(+)-terazosin
HUP0105231A3 (en) * 1999-02-11 2003-01-28 Pfizer Prod Inc Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents and medicaments containing the compounds
CA2429850C (en) 2000-11-27 2008-12-30 Pfizer Products Inc. Ep4 receptor selective agonists in the treatment of osteoporosis
US7335680B2 (en) 2001-12-20 2008-02-26 Laboratoires Serono Sa Pyrrolidine derivatives as prostaglandin modulators
US7141597B2 (en) 2003-09-12 2006-11-28 Allergan, Inc. Nonsedating α-2 agonists
NL1026830C2 (nl) * 2004-08-12 2006-02-14 Frederik Dirk Petrus Wolf Vishaak.
US7696243B2 (en) * 2004-12-06 2010-04-13 Merck Serono, S.A. Pyrrolidin-2-one derivatives for use as DP1 receptor agonists
US7091231B2 (en) * 2004-12-10 2006-08-15 Allergan, Inc. 12-Aryl prostaglandin analogs
ES2388929T3 (es) 2005-03-10 2012-10-19 Allergan, Inc. Gamma¿lactamas sustituidas como agentes terapéuticos
US7772392B2 (en) 2005-05-06 2010-08-10 Allergan, Inc. Therapeutic substituted β-lactams
JP5570807B2 (ja) * 2006-07-11 2014-08-13 アラーガン インコーポレイテッド 抗緑内障薬としてのシクロペンタン誘導体
BRPI0811781A2 (pt) * 2007-05-23 2014-11-11 Allergan Inc Compostos de ((fenil) imidazolil)metilquinolinila terapêuticos.
CA2703479C (en) * 2007-10-23 2017-08-22 Allergan, Inc. 1,5-substituted gamma-lactams
US7902247B2 (en) * 2008-01-09 2011-03-08 Allergan, Inc. Substituted-aryl-2-phenylethyl-1H-imidazole compounds as subtype selective modulators of alpha 2B and/or alpha 2C adrenergic receptors
US8063033B2 (en) 2008-01-18 2011-11-22 Allergan, Inc. Therapeutic beta-lactams

Also Published As

Publication number Publication date
AU2008254717B2 (en) 2014-06-05
EP2155733B1 (en) 2012-09-26
SI2155733T1 (sl) 2012-12-31
JP2010528030A (ja) 2010-08-19
US20100190823A1 (en) 2010-07-29
WO2008144623A1 (en) 2008-11-27
BRPI0812385A2 (pt) 2019-09-24
US8198315B2 (en) 2012-06-12
CY1113448T1 (el) 2016-06-22
PL2155733T3 (pl) 2013-02-28
JP5524047B2 (ja) 2014-06-18
PT2155733E (pt) 2013-01-07
AU2008254717A1 (en) 2008-11-27
ES2395875T3 (es) 2013-02-15
US20100160407A1 (en) 2010-06-24
US8383646B2 (en) 2013-02-26
EP2155733A1 (en) 2010-02-24
CA2688897A1 (en) 2008-11-23

Similar Documents

Publication Publication Date Title
DK2300443T3 (da) Triazolderivater, der er anvendelige til behandling af sygdomme
DK3714877T3 (da) Fremgangsmåde og sammensætning til behandling af okulær hypertension og glaukom
DK3308769T3 (da) Fremgangsmåder til fremstilling af cykliske lipidimplantater til intraokulær anvendelse
DK3456707T3 (da) 4-(p-quinonyl)-2-hydroxybutanamidderivater til behandling af mitokondriesygdomme
DK1868600T3 (da) Spirocyklisk cyclohexanderivat til behandling af stofafhængighed
DK2448637T3 (da) Anvendelse af ét fytocannabinoid eller en kombination af fytocannabinoider til behandling af epilepsi
DK2808024T3 (da) Bifidobakterier til behandling af kongestiv hjerteinsufficiens
DK2086944T3 (da) Fremgangsmåde til fremstilling af difluormethylpyrazolylcarboxylater
DK2207775T3 (da) 4-Benzylamino-1-carboxyacylpiperidinderivater som CETP-inhibitorer, som er anvendelige til behandling af sygdomme som hyperlipidæmi eller arteriosclerose
DK2240130T3 (da) Indretning til behandling af fedme
DK2114886T3 (da) Fremgangsmåde til fremstilling af visse substituerede sulfiliminer
DK2349310T3 (da) Polypeptid til behandling eller forebyggelse af adhæsioner
DK2451482T3 (da) Kombinationsterapi til behandlingen af diabetes
DK2451796T3 (da) Tofaanaloger til behandling af dermatologiske lidelser eller tilstande
DK2146732T3 (da) Fremgangsmåder til behandling eller forebyggelse af emese ved hjælp af væksthormonsekretagoger
DK2459553T3 (da) Furazanobenzimidazoler som prodrug til behandling af neoplastiske eller autoimmune sygdomme
DK2010184T3 (da) Implatanter til behandlingen af dopamin associerede tilstande
DK2148667T3 (da) Anvendelse af cyclohexanhexolderivater til behandling af øjensygdomme
DK2285808T3 (da) Spiroindolderivater til behandling af parasitsygdomme
FR2913196B1 (fr) Implant oculaire accomodatif
DK1846354T3 (da) Substituterede cyclopentaner eller cyclopentanoner til behandling af okular hypertensive tilstande
DK2382232T3 (da) Fremgangsmåde til fremstilling af bivalirudin
DK2321359T3 (da) Fremgangsmåde til behandling af naturlige gummiprodukter
DK3689346T3 (da) 3,6-disubstitueret xanthyliumsalte til behandling af tauopati
DK2117565T3 (da) Anvendelse af chitosaner til behandlingen af negleinflammatoriske sygdomme